# Shandong Xinhua Pharmaceutical Company Limited - Inspection Records

Source: https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-company-limited/7350901d-493e-45cb-a67f-c73093cf762e

> Inspection records and compliance data for Shandong Xinhua Pharmaceutical Company Limited in Zibo, None. Access full analysis and detailed observations.

---

## Details

- Name: Shandong Xinhua Pharmaceutical Company Limited
- FEI Number: 3004254526
- City: Zibo
- State: None
- Country Name: China
- Address Line 1: Hutian Chemical, Zhangdian
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [FDA Inspection 1237492 - Shandong Xinhua Pharmaceutical Company Limited - 2024-04-05](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-company-limited/b51d6e0b-a536-4115-820a-9e478884c09c) — classification: No Action Indicated (NAI), source: FDA, date: April 5, 2024
- [FDA Inspection 1087221 - Shandong Xinhua Pharmaceutical Company Limited - 2019-03-29](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-company-limited/92338ae1-9f91-46e4-bd2c-776ae27f2a10) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2019
- [FDA Inspection 1087221 - Shandong Xinhua Pharmaceutical Company Limited - 2019-03-29](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-company-limited/8cabcfe8-ae79-4a6c-a609-014d0772be81) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2019
- [483 - Shandong Xinhua Pharmaceutical Company Limited - 2019-03-25](https://www.keypedia.com/records/483/shandong-xinhua-pharmaceutical-company-limited/c944c50e-057c-4ae8-b8ce-4de9d48b6efa) — source: FDA, date: March 25, 2019
- [FDA Inspection 997761 - Shandong Xinhua Pharmaceutical Company Limited - 2016-03-31](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-company-limited/b4b9957b-25e4-450b-91ef-6d6159f6ba3a) — classification: No Action Indicated (NAI), source: FDA, date: March 31, 2016
- [FDA Inspection 876774 - Shandong Xinhua Pharmaceutical Company Limited - 2014-04-04](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-company-limited/a124a9af-f1c7-49e0-801f-9d58ab859df0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 4, 2014

## Related Companies

- [Cambrex Charles City, Inc.](https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6)
- [Livzon New North River Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-new-north-river-pharmaceutical-co-ltd/49cdcdc8-9c6c-4486-b6cd-e404c21dd2d2)
- [Olon S.p.A.](https://www.keypedia.com/companies/olon-spa/7e0ac35e-0f38-43f3-8415-015a3d5c0248)
- [Nippon Protein Co., Ltd. Ashikaga Plant](https://www.keypedia.com/companies/nippon-protein-co-ltd-ashikaga-plant/ccd4e515-8d9e-4f63-9a5d-b117cf2659d6)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/d87c0898-93b6-4200-b7b3-805ee819abb4)
- [AstraZeneca Pharmaceuticals, LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/24c4d7fa-217f-4286-8074-011be79e658f)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/882d7962-58d4-4de8-9d0b-86bf2cf4773e)
- [Medichem, S.A.](https://www.keypedia.com/companies/medichem-sa/a0e6f1b5-f2ab-4695-a0e9-007630ef1270)
- [Neuland Laboratories Limited (Unit I)](https://www.keypedia.com/companies/neuland-laboratories-limited-unit-i/2ab72f34-8d5a-4919-8777-83a4fa3cadd5)
- [Cambrex Karlskoga AB](https://www.keypedia.com/companies/cambrex-karlskoga-ab/c3f2350f-a38e-4e0c-9bac-e94c0255764c)

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)